| AI-generated medical advice—GPT and beyond CE Haupt, M Marks Jama 329 (16), 1349-1350, 2023 | 257 | 2023 |
| AI chatbots, health privacy, and challenges to HIPAA compliance M Marks, CE Haupt Jama 330 (4), 309-310, 2023 | 95 | 2023 |
| Artificial Intelligence Based Suicide Prediction M Marks Yale Journal of Health Policy, Law, and Ethics 18, 36, 2019 | 80 | 2019 |
| Psychedelic therapy: a roadmap for wider acceptance and utilization M Marks, IG Cohen Nature Medicine 27 (10), 1669-1671, 2021 | 67 | 2021 |
| Psychedelic Medicine for Mental Illness and Substance Use Disorders: Overcoming Social and Legal Obstacles M Marks New York University Journal of Legislation & Public Policy 21 (1), 72, 2018 | 59 | 2018 |
| Patents on psychedelics: the next legal battlefront of drug development M Marks, IG Cohen Harv. L. Rev. F. 135, 212, 2021 | 48 | 2021 |
| Emergent medical data: health information inferred by artificial intelligence M Marks UC Irvine L. Rev. 11, 995, 2020 | 47 | 2020 |
| The Varieties of Psychedelic Law M Marks https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4286450, 2022 | 45 | 2022 |
| Controlled Substance Regulation for the COVID-19 Mental Health Crisis M Marks Administrative Law Review 72, 2020 | 40 | 2020 |
| Robots in space: Sharing the sidewalk with autonomous delivery vehicles M Marks Available at SSRN 3347466, 2019 | 33* | 2019 |
| Governing AI‐driven health research: Are IRBs up to the task? P Friesen, R Douglas‐Jones, M Marks, R Pierce, K Fletcher, A Mishra, ... Ethics & Human Research 43 (2), 35-42, 2021 | 30 | 2021 |
| Biosupremacy: Big Data, Antitrust, and Monopolistic Power Over Human Behavior M Marks U.C. Davis Law Review 55, 2021 | 21 | 2021 |
| Essentials of informed consent to psychedelic medicine M Marks, RW Brendel, C Shachar, IG Cohen JAMA psychiatry 81 (6), 611-617, 2024 | 19 | 2024 |
| Returning individual research results from digital phenotyping in psychiatry FX Shen, ML Baum, N Martinez-Martin, AS Miner, M Abraham, ... The American Journal of Bioethics 24 (2), 69-90, 2024 | 17 | 2024 |
| Algorithmic disability discrimination M Marks Disability, Health, Law and Bioethics (Cambridge University Press, 2020), 2019 | 17 | 2019 |
| Automating FDA regulation M Marks Duke LJ 71, 1207, 2021 | 16 | 2021 |
| Developing an ethics and policy framework for psychedelic clinical care: a consensus statement AL McGuire, IG Cohen, D Sisti, M Baggott, Y Celidwen, N Devenot, ... JAMA Network Open 7 (6), e2414650-e2414650, 2024 | 14 | 2024 |
| Drug scheduling limits access to essential medicines and should be reformed M Marks, C Shachar Nature Medicine 29 (2), 294-297, 2023 | 12 | 2023 |
| Psychedelic medicine exceptionalism IG Cohen, M Marks The American Journal of Bioethics 25 (1), 6-15, 2025 | 11 | 2025 |
| State-regulated psychedelics on a collision course with FDA M Marks JAMA 330 (24), 2337-2338, 2023 | 8 | 2023 |
Claudia E. HauptNortheastern University School of Law; Yale Law School - Information Society ProjectVerified email at northeastern.edu
